North America Healthcare CRO Services Market, by Service Type, by End User, by Therapeutic Area, by Country, Industry Analysis and Forecast, 2019 - 2025

The North America Healthcare CRO Market is expected to witness market growth of 5.6% CAGR during the forecast period (2019-2025).

The healthcare industry has been to the big data party late. Nonetheless, as the adoption of big data for healthcare continues to evolve, it will gradually follow other industries' more complex consumer marketing behaviors. This maturation is focused on acknowledgment by health care leaders that they need to take a broader and more strategic view of the knowledge. Healthcare data management I Information management in healthcare is the process of preserving, securing and evaluating information derived from different sources. Managing the abundance of available data on healthcare allows health systems to create comprehensive patient experiences, customized treatments, enhance communication, and improve health outcomes.

Real-time health monitoring systems offer real-time analyses of the health parameters for the patient. Through these devices, patients exchange their health-care details with their providers in real-time for flexible health monitoring and management. The Internet of medical things significantly improves patients' health-care conditions. Due to the usage of the above IoT medical devices in the healthcare sector, tracking of patient monitoring and drug management has become possible. A growing aging population, increasing healthcare costs and a rise in the prevalence of chronic diseases are causing stakeholders in healthcare to strongly pursue remote health management and patient monitoring.

Based on Service Type, the market is segmented into Clinical Research Services, Early Phase Development, Laboratory Services and Consulting Services. Based on End User, the market is segmented into Pharmaceutical companies, Medical Device Companies and Academic Institutes. Based on Therapeutic Area, the market is segmented into Oncology, CNS Disorder, Cardiovascular Disease, Diabetes, Metabolic Diseases, Infectious Diseases and Other therapeutic areas. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include IQVIA Holdings, Inc., Laboratory Corporation of America Holdings (Covance, Inc.), Pharmaceutical Product Development, Inc., Parexel International Corporation (Pamplona Capital Management), Charles River Laboratories International, Inc., ICON PLC, Dassault Systemes SE (Medidata Solutions, Inc.), Syneos Health, Inc., Pharmaron Beijing Co., Ltd., and GVK Biosciences Private Limited.

Scope of the Study

Market Segmentation:

By Service Type

• Clinical Research Services
• Early Phase Development
• Laboratory Services and
• Consulting Services

By End User

• Pharmaceutical companies
• Medical Device Companies and
• Academic Institutes

By Therapeutic Area

• Oncology
• CNS Disorder
• Cardiovascular Disease
• Diabetes
• Metabolic Diseases
• Infectious Diseases and
• Other therapeutic areas

By Country

• US
• Canada
• Mexico
• Rest of North America

Companies Profiled

• IQVIA Holdings, Inc.
• Laboratory Corporation of America Holdings (Covance, Inc.)
• Pharmaceutical Product Development, Inc.
• Parexel International Corporation (Pamplona Capital Management)
• Charles River Laboratories International, Inc.
• ICON PLC
• Dassault Systemes SE (Medidata Solutions, Inc.)
• Syneos Health, Inc.
• Pharmaron Beijing Co., Ltd.
• GVK Biosciences Private Limited

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free